Hobbs Group Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,090
Closed -$201K 170
2025
Q4
$201K Buy
+2,090
New +$203K 0.06% 162
2025
Q3
Sell
-3,989
Closed -$348K 161
2025
Q2
$348K Buy
3,989
+3
+0.1% +$254 0.12% 120
2025
Q1
$358K Buy
+3,986
New +$357K 0.14% 109
2024
Q4
Sell
-1,606
Closed -$145K 423
2024
Q3
$145K Sell
1,606
-5,484
-77% -$461K 0.05% 167
2024
Q2
$558K Buy
+7,090
New +$581K 0.21% 79
2023
Q4
$663K Buy
+8,054
New +$614K 0.3% 59

Other funds holding MDT

Hobbs Group Advisors's MDT Position: Q1 2026 in Review

Hobbs Group Advisors sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,090 shares — an estimated $201K sold.

Hobbs Group Advisors first reported a position in MDT in Q4 2023 and held it in 6 quarters. The position peaked at $663K in Q4 2023. 2,252 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Hobbs Group Advisors reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Hobbs Group Advisors sold 2,090 Medtronic shares in Q1 2026, an estimated $201K.
  • Hobbs Group Advisors first reported a position in Medtronic in Q4 2023 and held it in 6 quarters.
  • Hobbs Group Advisors's Medtronic position peaked at $663K in Q4 2023.
  • 2,252 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Hobbs Group Advisors's 13F filing for Q1 2026, filed 20 May 2026.